Clinical pharmacokinetics of atomoxetine

JM Sauer, BJ Ring, JW Witcher - Clinical pharmacokinetics, 2005 - Springer
… Three oxidative metabolic pathways are involved in the systemic clearance of atomoxetine:
aromatic ring-hydroxylation, benzylic hydroxylation and N-demethylation. Aromatic ring-…

Present and future in vitro approaches for drug metabolism

S Ekins, BJ Ring, J Grace, DJ McRobie-Belle… - … of pharmacological and …, 2000 - Elsevier
The 1980s through 1990s witnessed the widespread incorporation of in vitro absorption,
distribution, metabolism, and excretion (ADME) approaches into drug development by drug …

The human drug metabolizing cytochromes P450

SA Wrighton, M VandenBranden, BJ Ring - Journal of pharmacokinetics …, 1996 - Springer
The superfamily of heme-thiolate proteins known as the cytochromes P450 is responsible for
the oxidative metabolism of the majority of drugs. Thus, the phenotypes of individuals with …

Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7

JA Williams, BJ Ring, VE Cantrell, DR Jones… - Drug Metabolism and …, 2002 - ASPET
… TAM has three ring aromatic features in its molecular structure, whereas the benzodiazepines
and DTZ each have two. The similar orientation of the ring aromatic features of these …

[PDF][PDF] Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine.

BJ Ring, J Catlow, TJ Lindsay, T Gillespie… - … of Pharmacology and …, 1996 - Citeseer
ABBREVIATIONS: 2-OH olanzapine, 2-hydroxy methyl olanzapine; NO olanzapine, 4-N-oxide
olanzapine; NdM olanzapine, 4’-N-desmethyl olanzapine; 7-OH olanzapine, 7-hydroxy …

Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450

…, SC Kasper, A Kurihara, SA Wrighton, BJ Ring - Drug Metabolism and …, 2006 - ASPET
… Further metabolism of R-95913 yields a ring-opened form, R-138727 (Fig. 1) (Sugidachi et
al., 2000, 2001), which has two chiral centers and is actually a mixture of four stereoisomers …

PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: Prediction of plasma concentration–time profiles in human by using the …

…, CR Gibson, M Rowland, JY Chien, BJ Ring… - Journal of …, 2011 - Elsevier
The objective of this study is to assess the effectiveness of physiologically based
pharmacokinetic (PBPK) models for simulating human plasma concentration–time profiles for the …

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance

BJ Ring, JY Chien, KK Adkison… - Journal of …, 2011 - Wiley Online Library
The objective of this study was to evaluate the performance of various allometric and in vitro–in
vivo extrapolation (IVIVE) methodologies with and without plasma protein binding …

[PDF][PDF] On minimum-uplift pricing for electricity markets

WW Hogan, BJ Ring - Electricity Policy Group, 2003 - lmpmarketdesign.com
… with the pricing analysis developed by Ring, recast here as minimum-uplift pricing, provides
an alternative equilibrium approach.A few conclusions emerge: • The IP formulation of the …

Identification of the human cytochromes P450 responsible for atomoxetine metabolism

BJ Ring, JS Gillespie, JA Eckstein… - Drug Metabolism and …, 2002 - ASPET
Studies were performed to determine the human enzymes responsible for the biotransformation
of atomoxetine to its major metabolite, 4-hydroxyatomoxetine, and to a minor metabolite,…